- Home
- Publications
- Publication Search
- Publication Details
Title
Effects of Medical Treatment of Prostate Cancer on Bone Health
Authors
Keywords
prostate cancer, bone mineral density, fractures, androgen deprivation, glucocorticoids
Journal
TRENDS IN ENDOCRINOLOGY AND METABOLISM
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2021-01-26
DOI
10.1016/j.tem.2020.12.004
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Glucocorticoids mediate adverse events of deep androgen receptor axis inhibition in prostate cancer patients
- (2020) S. Kaochar et al. ANNALS OF ONCOLOGY
- Treatment options for glucocorticoid-induced osteoporosis
- (2020) Iacopo Chiodini et al. EXPERT OPINION ON PHARMACOTHERAPY
- Acromegaly and Vertebral Fractures: Facts and Questions
- (2020) Andrea Giustina TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Glucocorticoids Enhanced Osteoclast Autophagy Through the PI3K/Akt/mTOR Signaling Pathway
- (2020) Lingjie Fu et al. CALCIFIED TISSUE INTERNATIONAL
- Pathogenesis of glucocorticoid-induced osteoporosis and options for treatment
- (2020) Pojchong Chotiyarnwong et al. Nature Reviews Endocrinology
- Olaparib for Metastatic Castration-Resistant Prostate Cancer
- (2020) Johann de Bono et al. NEW ENGLAND JOURNAL OF MEDICINE
- Oral Relugolix for Androgen-Deprivation Therapy in Advanced Prostate Cancer
- (2020) Neal D. Shore et al. NEW ENGLAND JOURNAL OF MEDICINE
- Consensus statement from 2nd International Conference on Controversies in Vitamin D
- (2020) A. Giustina et al. REVIEWS IN ENDOCRINE & METABOLIC DISORDERS
- Post-treatment levels of plasma 25- and 1,25-dihydroxy vitamin D and mortality in men with aggressive prostate cancer
- (2020) Visalini Nair-Shalliker et al. Scientific Reports
- Exercise and Nutritional Approaches to Combat Cancer-Related Bone and Muscle Loss
- (2020) Nicole Kiss et al. Current Osteoporosis Reports
- Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2020) C. Parker et al. ANNALS OF ONCOLOGY
- BONE HEALTH IN CANCER: ESMO CLINICAL PRACTICE GUIDELINES
- (2020) R. Coleman et al. ANNALS OF ONCOLOGY
- Bone Mineral Density and FRAX Score May Not Predict Fracture Risk in Patients With Cancer Undergoing Hormone Deprivation Therapies
- (2020) Alberto Dalla Volta et al. JOURNAL OF CLINICAL ONCOLOGY
- Effect of Androgen-Deprivation Therapy on Bone Mineral Density in Patients with Prostate Cancer: A Systematic Review and Meta-Analysis
- (2019) Do Kim et al. Journal of Clinical Medicine
- Glucocorticoid-induced osteoporosis: 2019 concise clinical review
- (2019) G. Adami et al. OSTEOPOROSIS INTERNATIONAL
- Darolutamide in Nonmetastatic, Castration-Resistant Prostate Cancer
- (2019) Karim Fizazi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Addition of radium-223 to abiraterone acetate and prednisone or prednisolone in patients with castration-resistant prostate cancer and bone metastases (ERA 223): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2019) Matthew Smith et al. LANCET ONCOLOGY
- Higher Risk of Fragility Fractures in Prostate Cancer Patients Treated with Combined Radium-223 and Abiraterone: Prednisone May Be the Culprit
- (2019) Alberto Dalla Volta et al. EUROPEAN UROLOGY
- Trabecular bone score and quantitative ultrasound measurements in the assessment of bone health in breast cancer survivors assuming aromatase inhibitors
- (2019) A. Catalano et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- ARCHES: A Randomized, Phase III Study of Androgen Deprivation Therapy With Enzalutamide or Placebo in Men With Metastatic Hormone-Sensitive Prostate Cancer
- (2019) Andrew J. Armstrong et al. JOURNAL OF CLINICAL ONCOLOGY
- Enzalutamide with Standard First-Line Therapy in Metastatic Prostate Cancer
- (2019) Ian D. Davis et al. NEW ENGLAND JOURNAL OF MEDICINE
- Apalutamide for Metastatic, Castration-Sensitive Prostate Cancer
- (2019) Kim N. Chi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Abiraterone in “High-” and “Low-risk” Metastatic Hormone-sensitive Prostate Cancer
- (2019) Alex P. Hoyle et al. EUROPEAN UROLOGY
- Cabazitaxel versus Abiraterone or Enzalutamide in Metastatic Prostate Cancer
- (2019) Ronald de Wit et al. NEW ENGLAND JOURNAL OF MEDICINE
- Risk of vertebral fractures in hypoparathyroidism
- (2019) Anna Maria Formenti et al. REVIEWS IN ENDOCRINE & METABOLIC DISORDERS
- Addition of docetaxel to hormonal therapy in low- and high-burden metastatic hormone sensitive prostate cancer: long-term survival results from the STAMPEDE trial
- (2019) N W Clarke et al. ANNALS OF ONCOLOGY
- Bone mineral density, structure, distribution and strength in men with prostate cancer treated with androgen deprivation therapy
- (2019) Jack Dalla Via et al. BONE
- Critical appraisal of definitions and diagnostic criteria for sarcopenic obesity based on a systematic review
- (2019) Lorenzo M. Donini et al. CLINICAL NUTRITION
- Trabecular bone score improves fracture risk assessment in glucocorticoid-induced osteoporosis
- (2019) Helena Florez et al. RHEUMATOLOGY
- Hormone‐related diseases and prostate cancer: An English national record linkage study
- (2019) Eleanor L. Watts et al. INTERNATIONAL JOURNAL OF CANCER
- Impact of taxanes on androgen receptor signaling
- (2018) Yan Dong et al. ASIAN JOURNAL OF ANDROLOGY
- Vitamin D assays and the definition of hypovitaminosis D: results from the First International Conference on Controversies in Vitamin D
- (2018) Christopher T. Sempos et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- The role of bisphosphonates or denosumab in light of the availability of new therapies for prostate cancer
- (2018) Fred Saad et al. CANCER TREATMENT REVIEWS
- Pituitary Diseases and Bone
- (2018) Gherardo Mazziotti et al. ENDOCRINE REVIEWS
- Glucocorticoids and bone: consequences of endogenous and exogenous excess and replacement therapy
- (2018) Rowan S Hardy et al. ENDOCRINE REVIEWS
- Glucocorticoid-Induced Osteoporosis: Management Challenges in Older Patients
- (2018) Robert A. Adler JOURNAL OF CLINICAL DENSITOMETRY
- Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer: Long-Term Survival Analysis of the Randomized Phase III E3805 CHAARTED Trial
- (2018) Christos E. Kyriakopoulos et al. JOURNAL OF CLINICAL ONCOLOGY
- Enzalutamide in Men with Nonmetastatic, Castration-Resistant Prostate Cancer
- (2018) Maha Hussain et al. NEW ENGLAND JOURNAL OF MEDICINE
- Apalutamide Treatment and Metastasis-free Survival in Prostate Cancer
- (2018) Matthew R. Smith et al. NEW ENGLAND JOURNAL OF MEDICINE
- Investigating the effect of testosterone by itself and in combination with letrozole on 1,25-dihydroxy vitamin D and FGF23 in male rats
- (2018) F. Saki et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- Phase II pilot study of the prednisone to dexamethasone switch in metastatic castration-resistant prostate cancer (mCRPC) patients with limited progression on abiraterone plus prednisone (SWITCH study)
- (2018) Nuria Romero-Laorden et al. BRITISH JOURNAL OF CANCER
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- MANAGEMENT OF ENDOCRINE DISEASE: Therapeutics of Vitamin D
- (2018) Peter Ebeling et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Skeletal and extra-skeletal actions of vitamin D: Current evidence and outstanding questions
- (2018) Roger Bouillon et al. ENDOCRINE REVIEWS
- French recommendations for osteoporosis prevention and treatment in patients with prostate cancer treated by androgen deprivation
- (2018) Karine Briot et al. JOINT BONE SPINE
- Controversies in Vitamin D: Summary Statement From an International Conference
- (2018) Andrea Giustina et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- MANAGEMENT OF ENDOCRINE DISEASE: Risk of overtreatment in patients with adrenal insufficiency: current and emerging aspects
- (2017) G Mazziotti et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Enzalutamide in Men with Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer: Extended Analysis of the Phase 3 PREVAIL Study
- (2017) Tomasz M. Beer et al. EUROPEAN UROLOGY
- An animal model of co-existing sarcopenia and osteoporotic fracture in senescence accelerated mouse prone 8 (SAMP8)
- (2017) Ning Zhang et al. EXPERIMENTAL GERONTOLOGY
- Darolutamide (ODM-201) for the treatment of prostate cancer
- (2017) Neal D. Shore EXPERT OPINION ON PHARMACOTHERAPY
- Phase III Study Comparing a Reduced Dose of Cabazitaxel (20 mg/m2) and the Currently Approved Dose (25 mg/m2) in Postdocetaxel Patients With Metastatic Castration-Resistant Prostate Cancer—PROSELICA
- (2017) Mario Eisenberger et al. JOURNAL OF CLINICAL ONCOLOGY
- Body composition and adipokines plasma levels in patients with myasthenia gravis treated with high cumulative glucocorticoid dose
- (2017) Nayara Felicidade Tomaz Braz et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer
- (2017) Karim Fizazi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy
- (2017) Nicholas D. James et al. NEW ENGLAND JOURNAL OF MEDICINE
- Long-term effect of aromatase inhibitors on bone microarchitecture and macroarchitecture in non-osteoporotic postmenopausal women with breast cancer
- (2017) A. R. Hong et al. OSTEOPOROSIS INTERNATIONAL
- 2017 American College of Rheumatology Guideline for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis
- (2017) Lenore Buckley et al. Arthritis & Rheumatology
- Awareness, concern, and communication between physicians and patients on bone health in nonmetastatic prostate cancer.
- (2017) Judd W. Moul et al. JOURNAL OF CLINICAL ONCOLOGY
- Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial
- (2016) Nicholas D James et al. LANCET
- Increasing incidence of metastatic prostate cancer in the United States (2004–2013)
- (2016) A B Weiner et al. PROSTATE CANCER AND PROSTATIC DISEASES
- A concise review of testosterone and bone health
- (2016) Nur Vaizura Mohamad et al. Clinical Interventions in Aging
- Enzalutamide: targeting the androgen signalling pathway in metastatic castration-resistant prostate cancer
- (2015) Jack Schalken et al. BJU INTERNATIONAL
- Integrative Clinical Genomics of Advanced Prostate Cancer
- (2015) Dan Robinson et al. CELL
- Bone metastasis and the metastatic niche
- (2015) Guangwen Ren et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Abiraterone acetate plus prednisone versus placebo plus prednisone in chemotherapy-naive men with metastatic castration-resistant prostate cancer (COU-AA-302): final overall survival analysis of a randomised, double-blind, placebo-controlled phase 3 study
- (2015) Charles J Ryan et al. LANCET ONCOLOGY
- Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer
- (2015) Christopher J. Sweeney et al. NEW ENGLAND JOURNAL OF MEDICINE
- Fracture risk in oral glucocorticoid users: a Bayesian meta-regression leveraging control arms of osteoporosis clinical trials
- (2015) M. A. Amiche et al. OSTEOPOROSIS INTERNATIONAL
- The impact of glucocorticoid therapy on trabecular bone score in older women
- (2015) M. A. Paggiosi et al. OSTEOPOROSIS INTERNATIONAL
- Assessing information needs on bone health in cancer survivors
- (2015) Jude K. A. des Bordes et al. Journal of Cancer Survivorship
- The obesity of bone
- (2015) Emanuela A. Greco et al. Therapeutic Advances in Endocrinology and Metabolism
- Denosumab for the prevention of skeletal complications in metastatic castration-resistant prostate cancer: comparison of skeletal-related events and symptomatic skeletal events
- (2014) M. R. Smith et al. ANNALS OF ONCOLOGY
- Abnormalities in Cortical Bone, Trabecular Plates, and Stiffness in Postmenopausal Women Treated With Glucocorticoids
- (2014) Stephanie Sutter et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Incremental Predictive Value of Sarcopenia for Incident Fracture in an Elderly Chinese Cohort: Results From the Osteoporotic Fractures in Men (MrOs) Study
- (2014) Ruby Yu et al. Journal of the American Medical Directors Association
- Efficacy and safety of radium-223 dichloride in patients with castration-resistant prostate cancer and symptomatic bone metastases, with or without previous docetaxel use: a prespecified subgroup analysis from the randomised, double-blind, phase 3 ALSYMPCA trial
- (2014) Peter Hoskin et al. LANCET ONCOLOGY
- Awareness, concern, and communication between physicians and patients on bone health in cancer
- (2014) Debu Tripathy et al. SUPPORTIVE CARE IN CANCER
- Vitamin D and Its Relationship with Obesity and Muscle
- (2014) Cristiana Cipriani et al. International Journal of Endocrinology
- Osteosarcopenic obesity: the role of bone, muscle, and fat on health
- (2014) Michael J. Ormsbee et al. Journal of Cachexia Sarcopenia and Muscle
- Glucocorticoids and the regulation of growth hormone secretion
- (2013) Gherardo Mazziotti et al. Nature Reviews Endocrinology
- Changes in bone mineral density in men starting androgen deprivation therapy and the protective role of vitamin D
- (2013) S. M. H. Alibhai et al. OSTEOPOROSIS INTERNATIONAL
- Osteoporosis in the European Union: medical management, epidemiology and economic burden
- (2013) E. Hernlund et al. Archives of Osteoporosis
- Management and challenges of corticosteroid therapy in men with metastatic castrate-resistant prostate cancer
- (2012) T. B. Dorff et al. ANNALS OF ONCOLOGY
- A Phase 3, Double-blind, Randomised, Parallel-group, Placebo-controlled Study of Oral Weekly Alendronate for the Prevention of Androgen Deprivation Bone Loss in Nonmetastatic Prostate Cancer: The Cancer and Osteoporosis Research with Alendronate and Leuprolide (CORAL) Study
- (2012) Laurence H. Klotz et al. EUROPEAN UROLOGY
- Randomized, Double-Blinded, Placebo-Controlled, Trial of Risedronate for the Prevention of Bone Mineral Density Loss in Nonmetastatic Prostate Cancer Patients Receiving Radiation Therapy Plus Androgen Deprivation Therapy
- (2012) Richard Choo et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Vertebral fractures and trabecular microstructure in men with prostate cancer on androgen deprivation therapy
- (2012) Susan L Greenspan et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Toremifene to Reduce Fracture Risk in Men Receiving Androgen Deprivation Therapy for Prostate Cancer
- (2012) Matthew R. Smith et al. JOURNAL OF UROLOGY
- Abiraterone acetate for treatment of metastatic castration-resistant prostate cancer: final overall survival analysis of the COU-AA-301 randomised, double-blind, placebo-controlled phase 3 study
- (2012) Karim Fizazi et al. LANCET ONCOLOGY
- Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy
- (2012) Howard I. Scher et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Current Practice of Screening, Prevention, and Treatment of Androgen-Deprivation-Therapy Induced Osteoporosis in Patients with Prostate Cancer
- (2012) Humaid O. Al-Shamsi et al. Journal of Oncology
- Association of hypogonadism with vitamin D status: the European Male Ageing Study
- (2011) David M Lee et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Vertebral Fractures and the Misclassification of Osteoporosis in Men With Prostate Cancer
- (2011) Sarah Sullivan et al. JOURNAL OF CLINICAL DENSITOMETRY
- Association of Glucocorticoid Use and Low 25-Hydroxyvitamin D Levels: Results from the National Health and Nutrition Examination Survey (NHANES): 2001–2006
- (2011) Amy L. Skversky et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study
- (2011) Karim Fizazi et al. LANCET
- Abiraterone and Increased Survival in Metastatic Prostate Cancer
- (2011) Johann S. de Bono et al. NEW ENGLAND JOURNAL OF MEDICINE
- Diabetes in Cushing syndrome: basic and clinical aspects
- (2011) Gherardo Mazziotti et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Drug-induced Osteoporosis: Mechanisms and Clinical Implications
- (2010) Gherardo Mazziotti et al. AMERICAN JOURNAL OF MEDICINE
- Glucocorticoid replacement therapy and vertebral fractures in hypopituitary adult males with GH deficiency
- (2010) G Mazziotti et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Structural Decay of Bone Microarchitecture in Men with Prostate Cancer Treated with Androgen Deprivation Therapy
- (2010) E. J. Hamilton et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial
- (2010) Johann Sebastian de Bono et al. LANCET
- Vertebral fractures in males with type 2 diabetes treated with rosiglitazone
- (2009) Tatiana Mancini et al. BONE
- Metabolic Complications of Androgen Deprivation Therapy for Prostate Cancer
- (2009) Philip J. Saylor et al. JOURNAL OF UROLOGY
- Denosumab in Men Receiving Androgen-Deprivation Therapy for Prostate Cancer
- (2009) Matthew R. Smith et al. NEW ENGLAND JOURNAL OF MEDICINE
- Development of a Second-Generation Antiandrogen for Treatment of Advanced Prostate Cancer
- (2009) C. Tran et al. SCIENCE
- Endogenous Sex Hormones and Incident Fracture Risk in Older MenThe Dubbo Osteoporosis Epidemiology Study
- (2008) Christian Meier ARCHIVES OF INTERNAL MEDICINE
- The efficacy and safety of degarelix: a 12-month, comparative, randomized, open-label, parallel-group phase III study in patients with prostate cancer
- (2008) Laurence Klotz et al. BJU INTERNATIONAL
- Incidence and risk factors for low trauma fractures in men with prostate cancer
- (2008) Henrik G. Ahlborg et al. BONE
- Maintenance of Intratumoral Androgens in Metastatic Prostate Cancer: A Mechanism for Castration-Resistant Tumor Growth
- (2008) R. B. Montgomery et al. CANCER RESEARCH
- Aromatase inhibitor-associated bone loss in breast cancer patients is distinct from postmenopausal osteoporosis
- (2008) Peyman Hadji CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Growth Hormone, Insulin-Like Growth Factors, and the Skeleton
- (2008) Andrea Giustina et al. ENDOCRINE REVIEWS
- Older Men With Low Serum Estradiol and High Serum SHBG Have an Increased Risk of Fractures
- (2008) Dan Mellström et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Effect of Anastrozole on Bone Mineral Density: 5-Year Results From the Anastrozole, Tamoxifen, Alone or in Combination Trial 18233230
- (2008) Richard Eastell et al. JOURNAL OF CLINICAL ONCOLOGY
- Are Cancer Survivors/Patients Knowledgeable About Osteoporosis? Results from a Survey of 285 Chemotherapy-treated Cancer Patients and Their Companions
- (2008) Heidi McKean et al. JOURNAL OF NUTRITION EDUCATION AND BEHAVIOR
- Sarcopenic obesity: A new category of obesity in the elderly
- (2008) Mauro Zamboni et al. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
- Androgens and bone
- (2008) Bart L. Clarke et al. STEROIDS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now